The ‘inner terror’ of lethal injection is cruel, law prof argues in bid to stop Gunches execution
Death by lethal injection looks like the condemned person just went to sleep. But looks can be deceiving. Anesthesiologists ...
The American Journal of Managed Care4d
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
FiercePharma4d
Bristol Myers celebrates 10 years of Opdivo with FDA approval for subcutaneous version
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...
조선일보5d
Researchers leverage snake venom components to develop new hypertension treatments
Researchers leverage snake venom components to develop new hypertension treatments Innovative compounds in snake venom spark ...
FDA approves subcutaneous opdivo qvantig for most solid tumor indications
The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for ...
An Arizona prisoner is asking to be executed sooner than the state wants
An Arizona death row prisoner asked the state’s highest court to skip legal formalities and schedule his execution earlier ...
BioSpace4d
2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US
Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s ...
After holiday pause, South Carolina begins scheduling executions again
South Carolina's Supreme Court set a Jan. 31 date for the state's next execution after allowing a pause for the Christmas ...
Tennessee is refusing to release its new execution manual. Here is why it matters.
Just days after Tennessee announced it had a new manual for executing death row inmates, the state's top prison officials ...
UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
Merck's Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise ...
INLIF LIMITED Announces Closing of US$8 Million Initial Public Offering
INLIF LIMITED (Nasdaq: INLF) (the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding ...